Peripheral neuropathy Board decisions

The Board granted an initial 50 percent rating for peripheral neuropathy of the right upper extremity and a 40 percent rating for the left, as well as special monthly compensation based on aid and attendance.

The Board remands the claims for service connection for bilateral lower extremity peripheral neuropathy due to a finding that an adequate VA medical opinion was not obtained.

The Veteran is granted special monthly compensation (SMC) based on the need for regular aid and attendance due to his service-connected disabilities.

The Board denied the veteran's claims for increased ratings and entitlement to a total disability rating based on individual unemployability due to service-connected disabilities.

The Board denied service connection for various conditions, including left and right eye dry eyes, cataracts of the left and right eyes, neuropathy of the left lower extremity, radiculopathy of the right lower extremity, left renal arteriovenous malformation, aneurysm, pseudofolliculitis barbae (PFB), degenerative joint disease (DJD) of the lumbar spine, recurrent subluxation of the left knee prior to May 13, 2020, left total knee replacement, disability rating in excess of 60 percent from September 1, 2021, forward for left total knee replacement, DJD of the right knee, right knee instability, burns of the bilateral ankles, linear scar of the left knee, post-surgical tender scars of the left knee, and a total disability rating due to unemployability (TDIU) based upon service-connected disabilities prior to June 14, 2019.

The Board remands the claims for service connection for various conditions, including a lumbar spine condition, cervical spine condition, bilateral upper and lower peripheral neuropathy, and an acquired psychiatric condition, as further development is needed to properly adjudicate these claims.

The Board remands the claims for earlier effective dates and increased ratings to cure a pre-decisional duty to assist error related to the Veteran's exposure to herbicide agents in Thailand.

The Board denied service connection for bilateral hearing loss and denied increased ratings for sleep apnea, left ankle scar, painful left ankle scar, acquired psychiatric disability (major depressive disorder and generalized anxiety disorder), left foot metatarsalgia, and right knee limitation of flexion. The Board granted a 20 percent rating for left foot neuropathy and 20 percent rating for right knee limitation of extension.

The Board granted earlier effective dates for service connection and special monthly compensation based on housebound criteria, effective March 24, 2022.

The Board granted readjudication of the claims for service connection for diabetes mellitus, prostate cancer, and peripheral neuropathy of the left and right lower extremities due to new and relevant evidence having been received.

The appeal was dismissed due to a procedural defect related to the submission of the Notice of Disagreement by the Claimant prior to approval of her request for substitution as claimant following the Veteran's death.

The Board remands the issues of entitlement to a disability rating in excess of 40 percent for diabetes mellitus, type II, and initial ratings for peripheral neuropathy in both upper extremities due to missing records from MS Medical Group.

The Board denied the Veteran's appeal for a higher level of special monthly compensation (SMC) as he does not meet the criteria for an increased rate based on his service-connected disabilities.

The Board granted a 30 percent rating for asthma but denied all other claims, including service connection for various conditions and a compensable rating for scars between the scapulae.

The Board remands the claims for service connection for thyroid condition, diabetes, eye condition, and peripheral neuropathy to correct pre-decisional duty to assist errors.

The appeal was dismissed due to the Veteran's request for higher-level review of effective dates being improperly denied by VA.

The Board denied an increased rating for diabetes mellitus, type II and granted a 30 percent rating for right upper extremity peripheral neuropathy. The claims for increased ratings for left upper extremity PN, right lower extremity PN, and left lower extremity PN were denied, as was the claim for service connection for hyperlipidemia.

The Board denied the Veteran's claims for higher initial ratings for peripheral neuropathy of both lower extremities, finding that his symptoms did not meet the criteria for a compensable rating.

The Board remands the claims for service connection for various disabilities, including bilateral hearing loss, tinnitus, heart disability, diabetes mellitus, and neuropathy, to obtain additional evidence and a new medical opinion.

The Board granted a total disability rating based on individual unemployability (TDIU) effective July 20, 2021, but denied an initial disability rating in excess of 50 percent for obstructive sleep apnea.